Advances in Peptide and Peptidomimetic Design Inspiring Basic Science and Drug Discovery: A Themed Issue Honoring Professor Victor J. Hruby on the Occasion of His 80th Birthday
Advances in Peptide and Peptidomimetic Design Inspiring Basic Science and Drug Discovery is a book dedicated to Prof. Victor J. Hruby on the occasion of his 80th birthday. This book includes twenty contributions from authors representing diverse multidisciplinary fields of scientific expertise, and...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , |
| Format: | Book Chapter |
| Published: |
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 05090naaaa2201585uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_40330 | ||
| 005 | 20210211 | ||
| 020 | |a books978-3-03928-289-0 | ||
| 020 | |a 9783039282890 | ||
| 020 | |a 9783039282883 | ||
| 024 | 7 | |a 10.3390/books978-3-03928-289-0 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 100 | 1 | |a Sawyer, Tomi |4 auth | |
| 700 | 1 | |a Haskell-Luevano, Carrie |4 auth | |
| 700 | 1 | |a Mosberg, Henry |4 auth | |
| 245 | 1 | 0 | |a Advances in Peptide and Peptidomimetic Design Inspiring Basic Science and Drug Discovery: A Themed Issue Honoring Professor Victor J. Hruby on the Occasion of His 80th Birthday |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
| 300 | |a 1 electronic resource (406 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Advances in Peptide and Peptidomimetic Design Inspiring Basic Science and Drug Discovery is a book dedicated to Prof. Victor J. Hruby on the occasion of his 80th birthday. This book includes twenty contributions from authors representing diverse multidisciplinary fields of scientific expertise, and is focused on the extraordinary potential of peptides and peptidomimetics as a surging therapeutic modality and as tools for basic research and technology development. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by-nc-nd/4.0/ |2 cc |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ | ||
| 546 | |a English | ||
| 653 | |a fusogenic | ||
| 653 | |a small molecule | ||
| 653 | |a cancer vaccine | ||
| 653 | |a peptide-drug conjugate | ||
| 653 | |a protein-protein interaction | ||
| 653 | |a anticancer peptide | ||
| 653 | |a tetrapeptides | ||
| 653 | |a drug discovery | ||
| 653 | |a ginkgo nuts | ||
| 653 | |a prostaglandin F2? | ||
| 653 | |a macrocyclic peptide | ||
| 653 | |a melanocortins | ||
| 653 | |a Toll-like receptor | ||
| 653 | |a polo-box domain | ||
| 653 | |a endosomolytic | ||
| 653 | |a structure-activity | ||
| 653 | |a free energy calculation | ||
| 653 | |a peptide | ||
| 653 | |a autophagy | ||
| 653 | |a synthetic vaccine | ||
| 653 | |a small antimicrobial peptides | ||
| 653 | |a azapeptides | ||
| 653 | |a classification | ||
| 653 | |a multifunctional ligands | ||
| 653 | |a cytoprotective | ||
| 653 | |a polycationic -amino acids | ||
| 653 | |a N-acetylated Pam2Cys | ||
| 653 | |a Pam2Cys | ||
| 653 | |a disulfide-rich scaffold | ||
| 653 | |a d-amino acid scan | ||
| 653 | |a VEGF165 | ||
| 653 | |a antibiotics | ||
| 653 | |a hyperdisulfide | ||
| 653 | |a peptides | ||
| 653 | |a random forest | ||
| 653 | |a pseudosubstrate | ||
| 653 | |a influenza hemagglutinin | ||
| 653 | |a Ranalexin | ||
| 653 | |a ?-ginkgotide | ||
| 653 | |a LIR motif | ||
| 653 | |a bioconjugation | ||
| 653 | |a peptide agonist | ||
| 653 | |a GnRH | ||
| 653 | |a molecular rotor dye | ||
| 653 | |a sensor chip | ||
| 653 | |a helix-breaker | ||
| 653 | |a Plk1 | ||
| 653 | |a antimicrobial activity | ||
| 653 | |a molecular dynamics | ||
| 653 | |a machine learning | ||
| 653 | |a melanocortin-4 receptor | ||
| 653 | |a kinase inhibitor | ||
| 653 | |a support vector machine | ||
| 653 | |a D-amino acid | ||
| 653 | |a drug screen | ||
| 653 | |a receptor desensitization | ||
| 653 | |a diabetes | ||
| 653 | |a opioids | ||
| 653 | |a selectivity | ||
| 653 | |a IP20 | ||
| 653 | |a aza-amino acids | ||
| 653 | |a bis-benzamide scaffold | ||
| 653 | |a G?S signaling | ||
| 653 | |a chemical linker | ||
| 653 | |a MC4R | ||
| 653 | |a LHRH | ||
| 653 | |a ?-hairpin | ||
| 653 | |a androgen receptor | ||
| 653 | |a adjuvant | ||
| 653 | |a high throughput screening | ||
| 653 | |a receptor internalization | ||
| 653 | |a peptide design | ||
| 653 | |a ?-helix mimetics | ||
| 653 | |a adaptogenic | ||
| 653 | |a obesity | ||
| 653 | |a cardiovascular profile | ||
| 653 | |a hypoxia | ||
| 653 | |a programmed cell death ligand protein 1 | ||
| 653 | |a PKA | ||
| 653 | |a neuropilin-1 | ||
| 653 | |a preterm labor | ||
| 653 | |a ?-sheet | ||
| 653 | |a PKI | ||
| 653 | |a MC3R | ||
| 653 | |a myometrium contractions | ||
| 653 | |a amphiphilic | ||
| 653 | |a structure-activity relationship | ||
| 653 | |a peptidomimetics | ||
| 653 | |a combinatorial chemistry | ||
| 653 | |a sepsis | ||
| 653 | |a coactivator PELP1 | ||
| 653 | |a OBOC | ||
| 653 | |a mixed-mode pharmacology | ||
| 653 | |a configuration | ||
| 653 | |a peptide permeability | ||
| 653 | |a triazole | ||
| 653 | |a stapled peptide | ||
| 653 | |a cysteine-rich peptides | ||
| 653 | |a GLP-1 | ||
| 653 | |a RBC lysis | ||
| 653 | |a mixed pharmacology | ||
| 653 | |a therapeutic peptides | ||
| 653 | |a opioid | ||
| 653 | |a peptidomimetic | ||
| 653 | |a prostate cancer | ||
| 653 | |a alanine scan | ||
| 653 | |a lipidation | ||
| 653 | |a peptide therapeutics | ||
| 653 | |a cancer | ||
| 653 | |a pharmacophore | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/2089 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/40330 |7 0 |z DOAB: description of the publication |